PAVmed Inc (NASDAQ:PAVM) — Market Cap & Net Worth
Market Cap & Net Worth: PAVmed Inc (PAVM)
PAVmed Inc (NASDAQ:PAVM) has a market capitalization of $3.61 Million ($3.61 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29273 globally and #5980 in its home market, demonstrating a -16.95% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PAVmed Inc's stock price $3.92 by its total outstanding shares 921284 (921.28K). Also see how large is PAVmed Inc's balance sheet for a full breakdown of the balance sheet.
PAVmed Inc Market Cap History: 2016 to 2026
PAVmed Inc's market capitalization history from 2016 to 2026. Data shows change from $95.35 Million to $3.66 Million (-31.97% CAGR). Also see PAVM cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
PAVmed Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.00% | #849 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #2724 of 3165 |
Weight: PAVmed Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
PAVmed Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PAVmed Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest PAVmed Inc stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.19x
PAVmed Inc's market cap is 0.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
PAVmed Inc's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $34.00 Million | $500.00K | -$50.35 Million | 67.99x | N/A |
| 2022 | $6.63 Million | $377.00K | -$88.98 Million | 17.59x | N/A |
| 2023 | $3.80 Million | $2.45 Million | -$64.17 Million | 1.55x | N/A |
| 2024 | $578.11K | $3.00 Million | $39.79 Million | 0.19x | 0.01x |
Competitor Companies of PAVM by Market Capitalization
Companies near PAVmed Inc in the global market cap rankings as of September 18, 2026. Review PAVM goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to PAVmed Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #229 globally with a market cap of $109.23 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.99 Billion | $102.36 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.60 |
| #229 | Stryker Corporation | NYSE:SYK | $109.23 Billion | $284.76 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
PAVmed Inc Historical Marketcap From 2016 to 2026
Between 2016 and today, PAVmed Inc's market cap moved from $95.35 Million to $ 3.66 Million, with a yearly change of -31.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.66 Million | +1698.01% |
| 2025 | $203.42K | -64.81% |
| 2024 | $578.11K | -84.77% |
| 2023 | $3.80 Million | -42.78% |
| 2022 | $6.63 Million | -80.49% |
| 2021 | $34.00 Million | +16.04% |
| 2020 | $29.30 Million | +76.67% |
| 2019 | $16.58 Million | +24.74% |
| 2018 | $13.29 Million | -57.90% |
| 2017 | $31.58 Million | -66.88% |
| 2016 | $95.35 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of PAVmed Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.61 Million USD |
| MoneyControl | $3.61 Million USD |
| MarketWatch | $3.61 Million USD |
| marketcap.company | $3.61 Million USD |
| Reuters | $3.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PAVmed Inc
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing… Read more